Evidence mapPaperPMID 31465811Full record

ArticleDiabetes research and clinical practice2020

Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: The CRONICAS Cohort Study.

Maria Lazo-Porras, Antonio Bernabe-Ortiz, Andrea Ruiz-Alejos, Liam Smeeth, Robert H Gilman, William Checkley, German Málaga, J Jaime Miranda

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Maria Lazo-PorrasCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; CONEVID Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: maria.lazo@upch.pe.
Antonio Bernabe-OrtizCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: antonio.bernabe@upch.pe.
Andrea Ruiz-AlejosCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: aoriette@gmail.com.
Liam SmeethFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: Liam.Smeeth@lshtm.ac.uk.
Robert H GilmanDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States; Área de Investigación y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru. Electronic address: gilmanbob@gmail.com.
William CheckleyDivision of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD, United States. Electronic address: wcheckl1@jhmi.edu.
German MálagaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; CONEVID Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Lima, Peru; Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: german.malaga@upch.pe.
J Jaime MirandaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: Jaime.Miranda@upch.pe.
Universidad Peruana Cayetano Heredia · PEJohns Hopkins Medicine · USLondon School of Hygiene & Tropical Medicine · GBPrisma · PE

Funding

FIC NIH HHS D71 TW010877FIC NIH HHS R21 TW009982Medical Research Council MR/P008984/1Medical Research Council MR/P02386X/1Medical Research Council MR/P024408/1NCI NIH HHS P20 CA217231NHLBI NIH HHS HHSN268200900033CNHLBI NIH HHS U01 HL114180NHLBI NIH HHS UM1 HL134590NIMH NIH HHS U19 MH098780Wellcome Trust
6 · The paper itself

Abstract

aimsThis study aimed to (1) estimate the prevalence of prediabetes according to different definitions, (2) evaluate regression to normal glucose levels and progression towards T2DM, and (3) determine factors associated with regression and progression across four diverse geographical settings in a Latin American country.

methodsThe CRONICAS Cohort Study was conducted in four different areas in Peru. Enrollment started in September 2010 and follow-up was conducted in 2013. Prediabetes, T2DM and normal glucose levels were determined according to definitions from the World Health Organization (WHO), American Diabetes Association (ADA), and National Institute for Health and Care Excellence (NICE). The main outcomes were regression to normal glucose levels and incidence of T2DM. Prevalence estimates and 95% confidence intervals (95% CI) were calculated. Crude and adjusted models using Poisson regression were performed and relative risk ratios (RRR) and 95% CI were calculated.

resultsAt baseline, the prevalence of prediabetes varied markedly by definition used: 6.5%(95% CI 5.6-7.6%), 53.6% (95% CI 51.6-55.6%), and 24.6% (95% CI 22.8-26.4%) according to WHO, ADA and NICE criteria, respectively. After 2.2  years of follow-up, in those with prediabetes, the cumulative incidence of regression to euglycemia ranged between 31.4% and 68.9%, whereas the incidence of T2DM varied from 5.5% to 28.8%. Factors associated with regression to normal glucose levels and progression to diabetes were age, body mass index, and insulin resistance.

conclusionsRegression from pre-diabetes back to euglycemia was much more common than progression to diabetes.

Indexed as

AgedCohort StudiesDiabetes MellitusDisease ProgressionFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedPrediabetic StatePrevalenceDiabetesDisease progressionInsulin resistanceLongitudinal studiesLow-and middle-income countriesNormal glucose levelsPeruPrediabetes

Identifiers

PMID31465811
PMCPMC7239508
OpenAlexW2970435834

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.